Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Emergent BioSolutions under several agreements signed with the Oxford university, GSK and the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) respectively, it has manufactured a modified vaccinia Ankara (MVA) Ebola Zaire vaccine candidate (MVA EBOZ) anticipated for use in a Phase 1 clinical study to be conducted by Professor Adrian Hill of the Jenner Institute.

  • Shri Ananth Kumar, Union Minister of Chemicals & Fertilizers launched ‘Pharma Jan Samadhan’ scheme which is a web enabled system for redressal of consumers grievances relating to pricing and availability of medicines, created by National Pharmaceutical Pricing Authority (NPPA).

  • US researchers have successfully used a dog to sniff out thyroid cancer in people who had not yet been diagnosed. The trained scent dog accurately identified whether patients' urine samples had thyroid cancer or were benign (noncancerous) 88.2 per cent of the time, researchers said.

  • To commercialise Ayurvedic medicines, National Research Development Corporation (NRDC) signed a pact with Central Council for Research in Ayurvedic Sciences (CCRAS). The scope of the Memorandum of Agreement (MOA) also includes providing Intellectual Property Rights (IPR) services to CCRAS in India and abroad.

  • India unveiled its indigenously developed and manufactured Rotavirus vaccine, claimed to be the world's cheapest at the rate of around Rs 60 per dose and aimed at boosting efforts to deal with diarrhoea that kills upto 80,000 children under 5 every year.

    [adsense:336x280:8701650588]

  • Pharmaceutical Major Lupin has entered into an agreement to acquire the balance 40% equity stake in South African generics major, Pharma Dynamics(PD) from its founders. As per the agreement, the founders will exercise their put option before March 31,2015, for the 40% equity stake it currently holds. On completion of this transaction, PD will become a wholly owned subsidiary of Lupin.

  • A young Indian scientist based in Germany has been awarded a grant of 1.5 million euros to investigate the role of gut microbiota in autoimmune diseases of the central nervous system such as Multiple Sclerosis. The Starting Grants of the European Research Council (ERC) seek to give talented scientists at an early stage in their careers the freedom to pursue their most creative ideas.

  • New Aggressive form of HIV discovered in CUBA

    A new aggressive form of HIV can progress to AIDS in just three years - so rapidly that patients may not even realise they were infected, scientists say. Engaging in unprotected sex with multiple partners increases the risk of contracting multiple strains of HIV. Once inside a host, these strains can recombine into a new variant of the virus, researchers said.

Subscribe to Pharma News